📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases. (2024)

First Author: Mitchell J

Attributed to: The Mexico City Prospective Study funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2024.05.10.24307164

PubMed Identifier: 38766261

Publication URI: http://europepmc.org/abstract/MED/38766261

Type: Journal Article/Review

Parent Publication: medRxiv : the preprint server for health sciences